These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 42722)

  • 1. Physical properties of betamethasone alcohol-polyethylene glycol 6000 solid dispersions [proceedings].
    Hargreaves BJ; Pearson JT; Connor P
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():47P. PubMed ID: 42722
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of polyethylene glycol molecular weight variation on the properties of glutethimide-polyethylene glycol solid dispersions.
    Ford JL
    Pharm Acta Helv; 1984; 59(9-10):280-8. PubMed ID: 6483928
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends.
    Janssens S; de Armas HN; D'Autry W; Van Schepdael A; Van den Mooter G
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1114-20. PubMed ID: 18502629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid dispersions of drugs in polyoxyethylene 40 stearate: dissolution rates and physico-chemical interactions [proceedings].
    Kaur R; Grant DJ
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():48P. PubMed ID: 42723
    [No Abstract]   [Full Text] [Related]  

  • 5. Solid dispersions of nimodipine and polyethylene glycol 2000: dissolution properties and physico-chemical characterisation.
    Urbanetz NA; Lippold BC
    Eur J Pharm Biopharm; 2005 Jan; 59(1):107-18. PubMed ID: 15567307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization Kinetics of Indomethacin/Polyethylene Glycol Dispersions Containing High Drug Loadings.
    Duong TV; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2015 Jul; 12(7):2493-504. PubMed ID: 26056715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour.
    Goddeeris C; Van den Mooter G
    Eur J Pharm Sci; 2008 Sep; 35(1-2):104-13. PubMed ID: 18644442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. USE OF POLYETHYLENE GLYCOL IN THE CONCENTRATION OF PROTEIN SOLUTIONS.
    HOWE AF; GROOM T; CARTER RG
    Anal Biochem; 1964 Dec; 9():443-53. PubMed ID: 14239481
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization and stability of solid dispersions based on PEG/polymer blends.
    Bley H; Fussnegger B; Bodmeier R
    Int J Pharm; 2010 May; 390(2):165-73. PubMed ID: 20132875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of structural variations of non-ionic surfactants on micellar properties and solubilization: variation of oxyethylene content on properties of C22 monoethers.
    Arnarson T; Elworthy PH
    J Pharm Pharmacol; 1982 Feb; 34(2):87-9. PubMed ID: 6121886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle size dependency of dissolution rate and human bioavailability of phenytoin in powders and phenytoin-polyethylene glycol solid dispersions.
    Yakou S; Umehara K; Sonobe T; Nagai T; Sugihara M; Fukuyama Y
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4130-6. PubMed ID: 6529807
    [No Abstract]   [Full Text] [Related]  

  • 12. Steady-state tryptophan fluorescence spectroscopy study to probe tertiary structure of proteins in solid powders.
    Sharma VK; Kalonia DS
    J Pharm Sci; 2003 Apr; 92(4):890-9. PubMed ID: 12661074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status of solid dispersions.
    Ford JL
    Pharm Acta Helv; 1986; 61(3):69-88. PubMed ID: 3520598
    [No Abstract]   [Full Text] [Related]  

  • 14. Physical properties of solid dispersions of poorly water-soluble drugs with enteric coating agents.
    Hasegawa A; Kawamura R; Nakagawa H; Sugimoto I
    Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3429-35. PubMed ID: 4085073
    [No Abstract]   [Full Text] [Related]  

  • 15. Enhancement of dissolution of cyclosporine A using solid dispersions with polyoxyethylene (40) stearate.
    Liu C; Zhu SJ; Zhou Y; Wei YP; Pei YY
    Pharmazie; 2006 Aug; 61(8):681-4. PubMed ID: 16964710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STRUCTURE OF MURAMIDASE (LYSOZYME). IV. EFFECTS OF ETHYLENE GLYCOL, POLYETHYLENE GLYCOL AND SUCROSE ON THE PHYSICO-CHEMICAL AND ENZYMATIC PROPERTIES OF MURAMIDASE.
    HAMAGUCHI K; HAYASHI K; IMOTO T; FUNATSU M
    J Biochem; 1964 Jan; 55():24-9. PubMed ID: 14116616
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissolution of acetylsalicylic acid from acetylsalicylic acid-polyethylene glycol 6000 coprecipitates.
    Asker AF; Whitworth CW
    Pharmazie; 1975 Aug; 30(8):530-1. PubMed ID: 1178776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
    Leonardi D; Barrera MG; Lamas MC; Salomón CJ
    AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The compression of granulates containing solid dispersions.
    Kinget R; Kemel R
    Pharmazie; 1985 Jul; 40(7):475-7. PubMed ID: 4048252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.